Literature DB >> 6339277

Furosemide assays and disposition in healthy volunteers and renal transplant patients.

L Z Benet, D E Smith, E T Lin, F Vincenti, J G Gambertoglio.   

Abstract

A variety of furosemide assays and their application to biological samples have been described over the past 2 decades. We describe development of a specific, sensitive assay appropriate for efficient measurement of large numbers of biological samples. With development of this methodology we have demonstrated that the putative 2-amino-4-chloro-5-sulfamoylanthranilic acid metabolite is an artifact of sample preparation. In addition, some preparative techniques overestimate furosemide because they hydrolyze the glucuronide conjugate back to the parent compound. Applications of this assay to studies of normal subjects and patients who have received kidney transplants demonstrate a relatively constant amount of glucuronide formation and evidence that this conjugation occurs in the kidney. We also show that patients with renal transplants who are resistant to the effects of furosemide appear to have decreased secretion of the drug into the urinary site of action, the mechanism of which is unknown.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339277

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  4 in total

1.  The urinary excretion of frusemide and its metabolites by kidney transplant patients.

Authors:  H Nakahama; Y Miwa; A Yamaji; Y Orita; Y Fukuhara; M Yanase; T Kamada; T Sonoda; M Ishibasi; Y Ichikawa
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide.

Authors:  T B Vree; M van den Biggelaar-Martea; C P Verwey-van Wissen
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

Review 3.  Furosemide pharmacokinetics and pharmacodynamics in health and disease--an update.

Authors:  M Hammarlund-Udenaes; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1989-02

4.  Hydrochlorothiazide does not increase furosemide's effects in end-stage renal disease.

Authors:  Wooseong Huh; Ha-Young Oh; Jin Suk Han; In-Jin Jang; Dong-Seok Yim
Journal:  Transl Clin Pharmacol       Date:  2017-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.